Is 201T1 a reliable agent in tumour imaging?

Nuclear Medicine Communications

Volumn 17, Issue 9, 1996, Pages 805-809

  Ozcan Z ^a   Burak, Z ^a   Erdem, S ^a   Duman, Y ^a   Ozcan C ^a   Basdemir G ^a   Ozacar T ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

THALLIUM 201; DIAGNOSTIC AGENT; THALLIUM;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; INFECTION; INTRAVENOUS DRUG ADMINISTRATION; RAT; SCINTISCANNING; TUMOR; ANIMAL; EVALUATION; HUMAN; NEOPLASM; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SPRAGUE DAWLEY RAT; STAPHYLOCOCCUS INFECTION; TUMOR RECURRENCE;

ANIMALS; EVALUATION STUDIES; HUMANS; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS; RATS; RATS, SPRAGUE-DAWLEY; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STAPHYLOCOCCAL INFECTIONS; THALLIUM RADIOISOTOPES;

EID: 0029658795     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1080/00006231-199609000-00012     Document Type: Article

References (41)

1. Aneri D, Basset JY, Lonchampt MF et al Diagnosis of cerebral lesions by thallium-201. Radiology 1978; 128: 417-422.
2. Kaplan WD, Takvorian T, Mornis JH, Rumbaugh CL, Connly BT, Atkins HL. Thallium-201 brain tumor imaging: A comparative study with pathological correlation. J Nucl Med 1987; 28: 47-52.
3. Kim KT, Black KL, Marciano D et al Thallium-201 SPECT imaging of brain tumors: Methods and results. J Nucl Med 1990; 31: 965-969.
4. Waxman AD, Ramanna L, Memsic LD et al Thallium scintigraphy in the evaluation of mass abnormalities of breast. J Nucl Med 1993; 34: 18-23.
5. Salvatore M, Carratu L, Porta E. Thallium-201 as a positive indicator for lung neoplasms: Preliminary experiments. Radiology 1976; 121: 487-488.
6. Tonami N, Shuke K, Yokoyama K et al. Thallium-201 single photon emission computed tomography in the evaluation of suspected lung cancer. J Nucl Med 1989; 30: 997-1004.
7. Duman Y, Burak A, Erdem S et al The value and limitations of 201T1 scintigraphy in the evaluation of lung lesions and post-therapy follow-up of primary lung carcinoma. Nucl Med Commun 1993; 14: 446-453.
8. Ochi H, Sawa H, Fukuda T et al. Thallium-201 chloride thyroid scintigraphy to evaluate benign and/or malignant nodules-usefulness of the delayed scan. Cancer 1982; 50: 236-240.
9. Hoefnagel CA, Delprat CC, Marcuse HR, de Vijlder JJM. Role of thallium-201 total body scintigraphy in follow-up thyroid carcinoma. J Nucl Med 1986; 27: 1854-1857.
10. Ramanna, L, Waxman AD, Waxman S et al. Tl-201 (Tl) scintigraphy in bone and soft-tissue sarcoma: Evaluation of tumor mass and viability. J Nucl Med 1988; 28: 854.
11. Caluser C, Macapinlac H, Healey J et al. The relationship between thallium uptake, blood flow, and blood pool activity in bone and soft tissue tumors. Clin Nucl Med 1992; 17: 565-572.
12. Nadel HR. Thallium-201 for oncologic imaging in children. Sem Nucl Med 1993; 23: 243-254.
13. Caluser Cl, Abdel-Dayem HM, Macapinlac HA et al. The value of thallium and three-phase bone scans in the evaluation of bone and soft tissue sarcomas. Eur J Nucl Med 1994; 21: 1198-1205.
14. van der Wall H, Murray IPC, Huckstep RL et al. The role of thallium scintigraphy in excluding malignancy in bone. Clin Nucl Med 1993; 18: 551-557.
15. Ramanna L, Waxman A, Binney G, Waxman S, Mirra J, Rosen G. Thallium-201 scintigraphy in bone sarcoma: Comparison with gallium-67 and technetium-MDP in the evaluation of chemotherapeutic response. J Nucl Med 1990; 31: 567-572.
16. Kostakoglu L, Panicek DM, Divgi CR et al Correlation of the findings of thallium-201 chloride scans with those of other imaging modalities and histology following therapy in patients with bone and soft tissue sarcomas. Eur J Nucl Med 1995; 11: 1232-1237.
17. Lebowitz E, Greene MW, Greene R et al. Thallium-201 for medical use. I. J Nucl Med 1975; 16: 151-155.
18. Bradley-Moore PR, Lebowitz E, Greene MW, Atkins HL, Ansari AN. Thallium-201 for medical use. II. J Nucl Med 1975; 16: 156-160.
19. Atkins HL, Budinger TF, Lebowitz E et al. Thallium-201 for medical use. Ill: Human distribution and physical imaging properties. J Nucl Med 1977; 18: 133-140.
20. Sessler MJ, Geek P, Maul FD et al. New aspects of cellular Tl-201 uptake: T + Na + 2C1-cotransport is the central mechanism of ion uptake. Nucl Med 1986; 25: 24-27.
21. Ito Y, Muranaka A, Harada T et al. Experimental study of tumor affinity of thallium-201 chloride. Eur J Nucl Med 1978; 3: 81-86.
22. Ando AA, Ando I, Katayama M et al. Biodistribution of 201 Tl in tumor bearing animals and inflammatory lesion induced animals. Eur J Nucl Med 1987; 12: 567-572.
23. Sahweil A, El Sayed M, Ziada G et al. Thallium-201 kinetics in malignant tumors. J Nucl Med 1986; 27: 1033.
24. Mountz JM, Raymond PA, McKeever PE et al. Specific localization of thallium 201 in human high-grade astrocytoma by microautoradiography. Cancer Res 1989; 49: 4053-4056.
25. Black KL, Hawkins RA, Kim KT, Becker DP, Lemer C, Marciano D. Use of thallium-201 SPECT to quantitate malignancy grade of gliomas. J Neurosurg 1989; 71: 342-346.
26. Togawa T, Suzuki A, Higuchi Y et al. 201 Tl to 67Ga crude uptake ratio in primary lung cancer with reference to histological type. Lung Cancer 1985; 25: 187-195.
27. Rosen G, Capparos S, Nirenberg A et al. Ewing’s sarcoma: A ten year experience with adjuvant chemotherapy. Cancer 1981; 47: 2204-2213.
28. Rosen G, Capparos S, Nirenberg A et al. Preoperative chemotherapy for osteogenic sarcoma: Selection of postoperative adjuvant chemotherapy based upon the response to primary tumor to preoperative chemotherapy. Cancer 1982; 49: 1221-1230.
29. Caluser C, Healey J, Macapinlac H et al Tl-201 uptake in recurrent pigmented villonodular synovitis: Correlation with three-phase bone imaging. Clin Nucl Med 1992; 17: 751-753.
30. Yang CJC, Seabold JE, Gurll NJ. Brown tumor of bone: A potential source of false-positive thallium-201 localization. J Nucl Med 1989; 30: 1264-1267.
31. Durak H, Aras T, Sungur C, Erbengi G, Bekdik CF. Tl-201 uptake in brown tumors of hyperparathyroidism. Clin Nucl Med 1991; 16: 931-935.
32. Giingor F, Yazici M, Egehan I et al. Thallium-210 uptake in myositis ossificans: Potential pitfall in diagnosis. Clin Nucl Med 1995; 20: 259-262.
33. Krasnow AZ, Collier BD, Isitman AT, Heilman RS, Peck DC. The clinical significance of unusual sites of thallium-201 uptake. Sem Nucl Med 1988; 18: 350-358.
34. Ando A, Ando I, Sanada S et al. Tumor and liver uptake models of Ga-67 citrate. Eur J Nucl Med 1985; 10: 262-268.
35. Kaplan WD, Southee ML, Annese MS et al Evaluating low and intermediate grade non-Hodgkin’s lymphoma (NL) with gallium-67 (Ga) and thallium-201 (Tl) imaging. J Nucl Med 1990; 31: 793.
36. El-Gazzar AH, Sahweil A, Abdel-Dayem HM et al. Experience with thallium-201 imaging in head and neck cancer. Clin Nucl Med 1988; 13: 286-289.
37. Waxman AD, Goldsmith MS, Greif PM et al. Differentiation of tumor versus sarcoidosis using thallium-201 in patients with hilar and mediastinal adenopathy. J Nucl Med 1987; 28: 561.
38. Tonami N, Matsuda H, Ooba H et al. Thallium-201 accumulation in cerebral candidiasis: Unexpected finding on SPECT. Clin Nucl Med 1990; 15: 397-400.
39. Aktolun C, Demirei D, Kir M et al. Technetium-99m-MIBI and thallium-201 uptake in pulmonary actinomycosis. J Nucl Med 1991; 32: 1429-1431.
40. Krishna L, Slizofski WJ, Katsetos CD et al. Abnormal intracerebral thallium localization in a bacterial abscess. J Nucl Med 1992; 33: 2017-2019.
41. Ueda T, Kaji Y, Wakisaka S et al. Time sequential single photon emission computed tomography studies in brain tumor using thallium-201. Eur J Nucl Med 1993; 20: 138-145.